miR ‐96‐5p regulates cervical cancer cell resistance to cisplatin by inhibiting lncRNA TRIM52‐AS1 and promoting IGF2BP2
Author:
Affiliation:
1. Department of Gynecology II Affiliated Hospital of Inner Mongolia Minzu University Tongliao Inner Mongolia China
Publisher
Wiley
Subject
General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/kjm2.12593
Reference40 articles.
1. Cervical cancer: A global health crisis
2. Chemotherapy and targeted therapy in the management of cervical cancer
3. Cervical Cancer: An Overview of Pathophysiology and Management
4. Cisplatin: The first metal based anticancer drug
5. Systemic therapy in cervical cancer: 30 years in review
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Role of microRNA-4739 in enhancing cisplatin chemosensitivity by negative regulation of RHBDD2 in human cervical cancer cells;Cellular & Molecular Biology Letters;2024-01-25
2. RNA binding proteins in cancer chemotherapeutic drug resistance;Frontiers in Cell and Developmental Biology;2024-01-24
3. Expression patterns of m6A RNA methylation regulators under apoptotic conditions in various human cancer cell lines;2023-08-14
4. miRNAs role in cervical cancer pathogenesis and targeted therapy: Signaling pathways interplay;Pathology - Research and Practice;2023-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3